Adam Mossoff on 7th Circuit’s AbbVie Decision
Bloomberg Law– ICLE Academic Affiliate Adam Mossoff was quoted by Bloomberg Law in a story about the 7th U.S. Circuit Court of Appeals’ decision that AbbVie Inc.’s patent portfolio for arthritis treatments is not anti-competitive. You can read full story here.
Still, George Mason University law professor Adam Mossoff, who participated in a Seventh Circuit amicus brief siding with AbbVie, said the appeals court decision came down on the side of strong patent protections.
“Populist rhetoric may work in policy debates—and plaintiffs’ rhetoric about so-called ‘thickets’ has influenced policymakers in DC—but thankfully, courts hold parties accountable to facts and evidence in protecting the legal rights of patent owners creating new drugs and driving the US innovation economy,” Mossoff said in an email.